BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27185744)

  • 21. The three-dimensional structure of two redox states of cyclophilin A from Schistosoma mansoni. Evidence for redox regulation of peptidyl-prolyl cis-trans isomerase activity.
    Gourlay LJ; Angelucci F; Baiocco P; Boumis G; Brunori M; Bellelli A; Miele AE
    J Biol Chem; 2007 Aug; 282(34):24851-7. PubMed ID: 17591771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cyclophilin A inhibition: targeting transition-state-bound enzyme conformations for structure-based drug design.
    Nagaraju M; McGowan LC; Hamelberg D
    J Chem Inf Model; 2013 Feb; 53(2):403-10. PubMed ID: 23312027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptidyl prolyl cis/trans-isomerases: comparative reactivities of cyclophilins, FK506-binding proteins, and parvulins with fluorinated oligopeptide and protein substrates.
    Golbik R; Yu C; Weyher-Stingl E; Huber R; Moroder L; Budisa N; Schiene-Fischer C
    Biochemistry; 2005 Dec; 44(49):16026-34. PubMed ID: 16331962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computational insight into small molecule inhibition of cyclophilins.
    Sambasivarao SV; Acevedo O
    J Chem Inf Model; 2011 Feb; 51(2):475-82. PubMed ID: 21194235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A library of fluorescent peptides for exploring the substrate specificities of prolyl isomerases.
    Zoldák G; Aumüller T; Lücke C; Hritz J; Oostenbrink C; Fischer G; Schmid FX
    Biochemistry; 2009 Nov; 48(43):10423-36. PubMed ID: 19785464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solution structure of the single-domain prolyl cis/trans isomerase PIN1At from Arabidopsis thaliana.
    Landrieu I; Wieruszeski JM; Wintjens R; Inzé D; Lippens G
    J Mol Biol; 2002 Jul; 320(2):321-32. PubMed ID: 12079389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aryl hetaryl ketones and thioketones as efficient inhibitors of peptidyl-prolyl cis-trans isomerases.
    Hediger T; Frank W; Schumann M; Fischer G; Braun M
    Chem Biodivers; 2012 Nov; 9(11):2618-34. PubMed ID: 23161639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic insights into Pin1 peptidyl-prolyl cis-trans isomerization from umbrella sampling simulations.
    Di Martino GP; Masetti M; Cavalli A; Recanatini M
    Proteins; 2014 Nov; 82(11):2943-56. PubMed ID: 25066180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity.
    Chen S; Zhao X; Tan J; Lu H; Qi Z; Huang Q; Zeng X; Zhang M; Jiang S; Jiang H; Yu L
    Eur J Pharmacol; 2007 Jun; 565(1-3):54-9. PubMed ID: 17449029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
    Wang XJ; Xu B; Mullins AB; Neiler FK; Etzkorn FA
    J Am Chem Soc; 2004 Dec; 126(47):15533-42. PubMed ID: 15563182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isoform-specific inhibition of cyclophilins.
    Daum S; Schumann M; Mathea S; Aumüller T; Balsley MA; Constant SL; de Lacroix BF; Kruska F; Braun M; Schiene-Fischer C
    Biochemistry; 2009 Jul; 48(26):6268-77. PubMed ID: 19480458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular docking study of macrocycles as Fk506-binding protein inhibitors.
    MacDonald CA; Boyd RJ
    J Mol Graph Model; 2015 Jun; 59():117-22. PubMed ID: 25978804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptidylprolyl cis/trans isomerase activity and molecular evolution of vertebrate Cyclophilin A.
    Ren LQ; Liu W; Li WB; Liu WJ; Sun L
    Yi Chuan; 2016 Aug; 38(8):736-45. PubMed ID: 27531612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
    Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV
    Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovering novel chemical inhibitors of human cyclophilin A: virtual screening, synthesis, and bioassay.
    Li J; Chen J; Gui C; Zhang L; Qin Y; Xu Q; Zhang J; Liu H; Shen X; Jiang H
    Bioorg Med Chem; 2006 Apr; 14(7):2209-24. PubMed ID: 16307882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermodynamics of cyclophilin catalyzed peptidyl-prolyl isomerization by NMR spectroscopy.
    Videen JS; Stamnes MA; Hsu VL; Goodman M
    Biopolymers; 1994 Feb; 34(2):171-5. PubMed ID: 8142586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. X-ray structure of peptidyl-prolyl cis-trans isomerase A from Mycobacterium tuberculosis.
    Henriksson LM; Johansson P; Unge T; Mowbray SL
    Eur J Biochem; 2004 Oct; 271(20):4107-13. PubMed ID: 15479239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A.
    Agarwal PK; Geist A; Gorin A
    Biochemistry; 2004 Aug; 43(33):10605-18. PubMed ID: 15311922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FRET-Based Assays to Determine Calpain Activity.
    McCartney CE; Davies PL
    Methods Mol Biol; 2019; 1915():39-55. PubMed ID: 30617794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
    Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.